Abstract
Tyrosinemia type II is an inborn error of metabolism caused by a deficiency in hepatic cytosolic aminotransferase. Affected patients usually present a variable degree of mental retardation, which may be related to the level of plasma tyrosine. In the present study we evaluated effect of chronic administration of L-tyrosine on the activities of citrate synthase, malate dehydrogenase, succinate dehydrogenase and complexes I, II, II-III and IV in cerebral cortex, hippocampus and striatum of rats in development. Chronic administration consisted of L-tyrosine (500 mg/kg) or saline injections 12 h apart for 24 days in Wistar rats (7 days old); rats were killed 12 h after last injection. Our results demonstrated that L-tyrosine inhibited the activity of citrate synthase in the hippocampus and striatum, malate dehydrogenase activity was increased in striatum and succinate dehydrogenase, complexes I and II-III activities were inhibited in striatum. However, complex IV activity was increased in hippocampus and inhibited in striatum. By these findings, we suggest that repeated administrations of L-tyrosine cause alterations in energy metabolism, which may be similar to the acute administration in brain of infant rats. Taking together the present findings and evidence from the literature, we hypothesize that energy metabolism impairment could be considered an important pathophysiological mechanism underlying the brain damage observed in patients with tyrosinemia type II.
Similar content being viewed by others
References
Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease. J Neurochem 73:1127–1137
Bertoni-Freddari C, Mocchegiani E, Malavolta M, Casoli T, Di Stefano G, Fattoretti P (2006) Synaptic and mitochondrial physiopathologic changes in the aging nervous system and the role of zinc ion homeostasis. Mech Ageing Dev 127:590–596
Bertorello AM, Hopfield JF, Aperia A, Greengard P (1990) Inhibition by dopamine of Na+, K + −ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature (London) 347:386–388
Bongiovanni R, Yamamoto BK, Simpson C, Jaskiw GE (2003) Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat. J Neurochem 87:310–317
Cassina A, Radi R (1996) Differential inhibitory Action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309–316
de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2011) Tyrosine inhibits creatine kinase activity in cerebral cortex of young rats. Metab Brain Dis 221:227–26
de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2012) Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. Mol Cell Biochem 364:253–261
De Prá SD, Ferreira GK, Carvalho-Silva M, Vieira JS, Scaini G, Leffa DD, Fagundes GE, Bristot BN, Borges GD, Ferreira GC, Schuck PF, Andrade VM, Streck EL (2014) L-tyrosine induces DNA damage in brain and blood of rats. Neurochem Res 39:202–207
Elghozi JL, Le Quan-Bui KH, Devynck MA, Meyer P (1983) Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat. Eur J Pharmacol 90(2–3):279–282
Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22:3312–3320
Ferreira GK, Carvalho-Silva M, Gonçalves CL, Vieira JS, Scaini G, Ghedim FV, Deroza PF, Zugno AI, Pereira TC, Oliveira GM, Kist LW, Bogo MR, Schuck PF, Ferreira GC, Streck EL (2012) L-tyrosine administration increases acetylcholinesterase activity in rats. Neurochem Int 61:1370–1374
Ferreira GK, Jeremias IC, Scaini G, Carvalho-Silva M, Gomes LM, Furlanetto CB, Morais MO, Schuck PF, Ferreira GC, Streck EL (2013a) Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain. Neurochem Res 38:1742–1746
Ferreira GK, Scaini G, Carvalho-Silva M, Gomes LM, Borges LS, Vieira JS, Constantino LS, Ferreira GC, Schuck PF, Streck EL (2013b) Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats. Neurotox Res 23:327–335
Ferreira GK, Scaini G, Jeremias IC, Carvalho-Silva M, Gonçalves CL, Pereira TC, Oliveira GM, Kist LW, Bogo MR, Schuck PF, Ferreira GC, Streck EL (2014) An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain. Mol Neurobiol 49:734–740
Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O’Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (Wash DC) 281:838–842
Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23–26
Garcia-Cazola A, Wolf IN, Serrano M, Moog U, Pérez-Dueñas B, Póo P, Pineda M, Campistol J, Hoffmann GF (2009) Mental retardion and inborn errors of metabolism. J Inherit Metab Dis 32:599–608
Gluck MR, Zeevalk GD (2004) Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson’s disease and catecholamine associated diseases. J Neurochem 91:788–795
Gluck M, Ehrhart J, Jayetilleke E, Zeevalk GD (2002) Inhibition of brain mitochondrial respiration by dopamine: involvement of H2O2 and hydroxyl radicals but not glutathione-protein-mixed disulfides. J Neurochem 82:66–74
Goldsmith LA, Kang E, Bienfang DC, Jimbow K, Gerald P, Baden HP (1973) Tyrosinemia with plantar and palmar keratosis and keratitis. J Pediatr 83:798–805
Guemouri L, Artur Y, Herbeth B, Jeandel C, Cuny G, Siest G (1991) Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 37:1932–1937
Hawkins RA, Mans AK, Biebuyck JF (1982) Amino acid supply to individual cerebral structures in awake and anesthetized rats. Am J Physiol 242:E1–E11
Held PK (2006) Disorders of tyrosine catabolism. Mol Genet Metab 88:103–106
Kalivas PW (2004) Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23–29
Kaushik P, Gorin F, Vali S (2007) Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J Comput Neurosci 22(2):147–160
Kilbride SM, Telford JE, Davey GP (2008) Age-related changes in H2O2 production and bioenergetics in rat brain synaptosomes. Biochim Biophys Acta 1777:783–788
Kitto GB (1969) Intra– and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods Enzymol XIII:106–116
Kuczenski R, Segal DS (2005) Stimulant actions in rodents: Implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57:1391–1396
LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484–1491
Lees GJ (1991) Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res Rev 16:283–300
Lemonnier F, Charpentier C, Odievre M, Larregue M, Lemonnier A (1979) Tyrosine aminotransferase isoenzyme deficiency. J Pediatr 94:931–932
Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Macêdo LG, Carvalho-Silva M, Ferreira GK, Vieira JS, Olegário N, Gonçalves RC, Vuolo FS, Ferreira GC, Schuck PF, Dal-Pizzol F, Streck EL (2013) Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats. Neurochem Res 38:2625–2630
Macsai MS, Schwartz TL, Hinkle D, Hummel MB, Mulhern MG, Rootman D (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophtalmol 132:522–527
Mitchell GA, Grompe M, Lambert M, Tanguay RM (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. Mc Graw-Hill, New York, pp 1977–1982
Morgane PJ, Austin-LaFrance RJ, Bronzino JD, Tonkiss J, Galler JR (1992) Malnutrition and the developing central nervous system. In: Isaacson RL, Jensen KF (eds) The vulnerable brain: nutrition and toxins. Plenum Publishing Corporation, New York, pp 3–44
Morre MC, Hefti F, Wurtman RJ (1980) Regional tyrosine levels in rat brain after tyrosine administration. J Neural Transm 49:45–50
Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449
Nishi A, Fisone G, Snyder GL, Dulubova I, Aperia A, Nairn AC, Greengard P (1999) Regulation of Na+, K + −ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J Neurochem 73:1492–1501
Rabinowitz LG, Williams LR, Anderson CE, Mazur A, Kaplan P (1995) Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. J Pediatr 126:266–269
Ramos AC, Ferreira GK, Carvalho-Silva M, Furlanetto CB, Gonçalves CL, Ferreira GC, Schuck PF, Streck EL (2013) Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats. Int J Dev Neurosci 31:303–307
Reichel A, Begley DJ, Ermisch A (1996) Arginine vasopressin reduces the blood–brain transfer of 1-tyrosine and 1-valine: further evidence of the effect of the peptide on the 1-system transporter at the blood–brain barrier. Brain Res 713:232–239
Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53
Russo PA, Mitchell GA, Tanguay RM (2001) Tyrosinemia: a review. Pediatr Dev Pathol 4:212–221
Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51
Sener RN (2005) Tyrosinemia-computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain. J Comput Assist Tomogr 29:323–325
Sgaravatti AM, Vargas BA, Zandoná BR, Deckmann KB, Rockenbach FJ, Moraes TB, Monserrat JM, Sgarbi MB, Pederzolli CD, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS (2008) Tyrosine promotes oxidative stress in cerebral cortex of young rats. Int J Dev Neurosci 26:551–559
Sgaravatti AM, Magnusson AS, de Oliveira AS, Rosa AP, Mescka CP, Zanin FR, Pederzolli CD, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS (2009) Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex. Metab Brain Dis 24:415–425
Sirinathsinghji DJ, Heavens RP, Sikdar SK (1988) In vivo studies on the dopamine re-uptake mechanism in the striatum of the rat: effects of benztropine, sodium and ouabain. Brain Res 438(1–2):399–403
Srere PA (1969) Citrate synthase. In: Lowenstein JM (ed) Methods in enzymology, citric acid cycle. Academic, New York, pp 3–11
Uylings HB (2000) Development of the cerebral cortex in rodents and man. Eur J Morphol 38:309–312
Valentine JS, Wertz DL, Lyons TJ, Liou LL, Goto JJ, Gralla EB (1998) The dark side of dioxygen biochemistry. Curr Opin Chem Biol 2:253–262
Valikhani M, Akhyani M, Jafari AK, Barzegari M, Toosi S (2005) Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report. J Eur Acad Dermatol Venereol 20:591–594
Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483–494
Acknowledgments
This research was supported by grants from Programa de Pós-graduação em Ciências da Saúde—Universidade do Extremo Sul Catarinense (UNESC), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferreira, G.K., Carvalho-Silva, M., Gomes, L.M. et al. The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility. Metab Brain Dis 30, 215–221 (2015). https://doi.org/10.1007/s11011-014-9615-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9615-3